Monitor future quarterly filings for revenue recognition from commercial contracts and customer deployments. The appointment of a director with commercial experience may signal progress, but no hard financial data supports a near-term catalyst.
Price Chart
Executive Summary
MDWerks appointed Jeff Hopmayer to its Board of Directors and issued a press release highlighting its molecular targeting technology platform, an independently appraised IP portfolio valued at approximately $400 million, signed commercial contracts, and customer deployments beginning in Q2 2026. The filing is a routine director appointment combined with forward-looking business updates; no financial results or guidance were provided.
Key Facts
- Board expanded from 5 to 6 directors; Jeff Hopmayer appointed as independent director.
- Hopmayer receives $5,000 quarterly cash retainer, 500,000 shares upon execution, and quarterly equity grants of $30,000 in shares based on VWAP.
- Press release states IP portfolio independently appraised at approximately $400 million.
- Company reports signed commercial contracts and customer deployments that began in Q2 2026.
- Estimated addressable markets for technology platform exceed $1.8 trillion globally.
- No financial statements, revenue, or earnings data included in the filing.
Financial Impact
No revenue or earnings disclosed; IP valuation of ~$400 million is a non-cash asset appraisal. Director compensation involves up to 500,000 shares upfront plus quarterly equity grants, creating potential dilution.
Risk Factors
- Forward-looking statements about commercial execution and addressable markets are unsubstantiated by current revenue.
- Equity compensation to director will increase share count and dilute existing holders.
- Company is OTCQB-listed with no current revenue disclosed, indicating early-stage risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-032828 |
| Exhibit: ex99-1.htm | 0001493152-26-032828 |
| Document: form8-k.htm | 0001493152-26-032828 |
| Document: 0001493152-26-032828-index-headers.html | 0001493152-26-032828 |
| Document: 0001493152-26-032828-index.html | 0001493152-26-032828 |
| Document: 0001493152-26-032828.txt | 0001493152-26-032828 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 9w ago | 8-K | $0.0539 $0.0736 | ▲ +36.55% | ▲ +35.35% | $0.0750 (+39.15%) |
Aug 3, 2026 12w ago | 8-K | $0.0610 $0.0539 | ▼ −11.64% | ▼ −12.88% | $0.0750 (+22.95%) |
Jul 10, 2026 15w ago | 8-K | $0.0610 $0.0600 | ▼ −1.64% | ▼ −4.82% | $0.0750 (+22.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers